Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Foghorn Therapeutics is a biotechnology company focused on developing precision cancer therapies by targeting the chromatin regulatory system, which controls gene expression. Using its proprietary Gene Traffic Control platform, it identifies and drug genetically defined dependencies in cancer cells. The company’s pipeline includes novel small molecule inhibitors, degraders, and disruptors, with a focus on oncology and potential applications in other diseases.
This description was generated via AI from an annual report. Updated about 1 year ago.